Nomination/Application Deadline: May 15, 2020.
Amanda Proudfoot is internationally recognized for her important contributions to the field of chemokine biology. Her research focused on the development of anti-inflammatory and anti-infective therapeutic agents and many of the advances in chemokine biology trace back to seminal discoveries made by her. Her group identified and characterized novel chemokines, including CXCL4 and CXCL8, and cloned the chemokine receptors CCR1, CCR2 and CCR4. She provided the first evidence that inhibition of HIV infection of primary macrophages could be achieved through inhibition of CCR5, leading to a new paradigm in the search for HIV inhibitors. Amanda’s research led to the elucidation of several important aspects of the immune system.
The ICIS Amanda Proudfoot Tribute Award
is bestowed on an individual whose research on chemokine biology has had an impact on the field early in his/her career. Graduate students and postdoctoral fellows are eligible for this Award. This annual award is presented at the annual ICIS Meeting.